Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders Volume 5, 2004 - Issue 2
Journal homepage
74
Views
20
CrossRef citations to date
0
Altmetric
Article

Xaliproden in amyotrophic lateral sclerosis: early clinical trials

Lucette Lacomblez Department of PharmacologyCorrespondence[email protected]‐hop‐paris.fr
,
Gilbert Bensimon Federation of Neurology Mazarin, Hôpital de la Salpêtrière, Paris, France
,
Patrice Douillet Sanofi‐Synthélabo Recherche, Montpellier, France
,
Valérie Doppler Department of Pharmacology
,
François Salachas Federation of Neurology Mazarin, Hôpital de la Salpêtrière, Paris, France
&
Vincent Meininger Sanofi‐Synthélabo Recherche, Montpellier, France
Pages 99-106 | Published online: 10 Jul 2009

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Ton Fang, Ahmad Al Khleifat, Daniel R Stahl, Claudia Lazo La Torre, Caroline Murphy, Carolyn Young, Pamela J Shaw, P Nigel Leigh & Ammar Al-Chalabi. (2017) Comparison of the King’s and MiToS staging systems for ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 18:3-4, pages 227-232.
Read now
John A Morren & Nestor Galvez-Jimenez. (2012) Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis. Expert Opinion on Investigational Drugs 21:3, pages 297-320.
Read now
Stefano Zoccolella, Andrea Santamato & Paolo Lamberti. (2009) Current and emerging treatments for amyotrophic lateral sclerosis. Neuropsychiatric Disease and Treatment 5, pages 577-595.
Read now

Articles from other publishers (17)

Douglas W. Zochodne. 2023. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment 569 598 .
Jeremy M. Shefner, Richard Bedlack, Jinsy A. Andrews, James D. Berry, Robert Bowser, Robert Brown, Jonathan D. Glass, Nicholas J. Maragakis, Timothy M. Miller, Jeffrey D. Rothstein & Merit E. Cudkowicz. (2022) Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers. JAMA Neurology 79:12, pages 1312.
Crossref
Davide Bassani, Matteo Pavan, Stephanie Federico, Giampiero Spalluto, Mattia Sturlese & Stefano Moro. (2022) The Multifaceted Role of GPCRs in Amyotrophic Lateral Sclerosis: A New Therapeutic Perspective?. International Journal of Molecular Sciences 23:9, pages 4504.
Crossref
Tereza Filipi, Zuzana Hermanova, Jana Tureckova, Ondrej Vanatko & Miroslava Anderova. (2020) Glial Cells—The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment. Journal of Clinical Medicine 9:1, pages 261.
Crossref
Dmitry Petrov, Colin Mansfield, Alain Moussy & Olivier Hermine. (2017) ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?. Frontiers in Aging Neuroscience 9.
Crossref
Cumara B. O'Carroll, Amelia K. Adcock & Bart M. Demaerschalk. 2015. Evidence‐Based Neurology: Management of Neurological Disorders. Evidence‐Based Neurology: Management of Neurological Disorders 219 234 .
Xiaowei W. Su, James R. Broach, James R. Connor, Glenn S. Gerhard & Zachary Simmons. (2014) Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research. Muscle & Nerve 49:6, pages 786-803.
Crossref
Lucie Ayach, Christophe Curti, Marc Montana, Pascale Pisano & Patrice Vanelle. (2013) Actualités dans le traitement étiologique de la sclérose latérale amyotrophique. Therapies 68:2, pages 93-106.
Crossref
Reto Baldinger, Hans Dieter Katzberg & Markus Weber. (2012) Treatment for cramps in amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Paul H. Gordon & Vincent Meininger. (2011) How can we improve clinical trials in amyotrophic lateral sclerosis?. Nature Reviews Neurology 7:11, pages 650-654.
Crossref
Michael Benatar, Jerome Kurent & Dan H Moore. (2009) Treatment for familial amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database of Systematic Reviews.
Crossref
Benjamin Rix Brooks. (2009) Managing amyotrophic lateral sclerosis: Slowing disease progression and improving patient quality of life. Annals of Neurology 65:S1, pages S17-S23.
Crossref
D. Bozyczko-Coyne & M. Williams. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II 193 228 .
Douglas Mitchell. 2007. Evidence‐based Neurology: Management of Neurological Disorders. Evidence‐based Neurology: Management of Neurological Disorders 234 243 .
P. Cintas. (2006) Quels sont les traitements médicamenteux étiologiques?. Revue Neurologique 162, pages 220-227.
Crossref
Axel Grothey. (2005) Clinical Management of Oxaliplatin-Associated Neurotoxicity. Clinical Colorectal Cancer 5, pages S38-S46.
Crossref
Edith G McGeer & Patrick L McGeer. (2005) Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis. BioDrugs 19:1, pages 31-37.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.